Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Benjamin Schwalm
Observed name:
B Schwalm
Institutions:
German Cancer Research Center,
University Hospital Heidelberg,
National Center for Tumor Diseases,
Hopp Children's Cancer Center Heidelberg,
Deutsches Konsortium für Translationale Krebsforschung
Observed institutions:
University of Calgary,
German Cancer Research Center,
University Hospital Heidelberg,
National Center for Tumor Diseases,
Hopp Children's Cancer Center Heidelberg,
Alberta Children's Hospital Research Institute,
Deutsches Konsortium für Translationale Krebsforschung
show all 7
ORCID:
0009-0009-9852-6978
Observed ORCID:
0009-0009-9852-6978
OpenAlex ID:
A5032355066
A biobank of patient-derived pediatric brain tumor models
2018
·
Sebastian Brabetz
, Sarah E. S. Leary
, et al.
·
Nature Medicine
·
177
PDF
Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma
2020
·
Johannes Gojo
, Bernhard Englinger
, et al.
·
Cancer Cell
·
156
PDF
The molecular landscape of ETMR at diagnosis and relapse
2019
·
Sander Lambo
, Susanne N. Gröbner
, et al.
·
Nature
·
145
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients
2017
·
Christin Schmidt
, Nil A Schubert
, et al.
·
Neuro-Oncology
·
50
Patient‐ and xenograft‐derived organoids recapitulate pediatric brain tumor features and patient treatments
2023
·
Chiara Lago
, Aniello Federico
, et al.
·
EMBO Molecular Medicine
·
43
Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir
2022
·
Marieke Gringmuth
, Jenny Walther
, et al.
·
International Journal of Molecular Sciences
·
9
PDF
Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma
2022
·
Sonja Krausert
, Sebastian Brabetz
, et al.
·
Neuro-Oncology Advances
·
9
Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor–ligand interactions
2025
·
Alexander Beck
, Lisa Gabler-Pamer
, et al.
·
Nature Cancer
·
7
Sensitivity profiling reveals consistent drug responses across preclinical neuroblastoma models
2026
·
Marlinde. C. Schoonbeek
, Marloes van Luik
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
The ITCC-P4 PDX platform of pediatric cancers for preclinical testing
2026
·
Aniello Federico
, Apurva Gopisetty
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
CAR T cells targeting the glycoprotein GD2 show potent antitumor efficacy in high-risk ependymoma models
2025
·
Antonio Carlos Tallon-Cobos
, Konstantinos Vazaios
, et al.
·
Journal of Clinical Investigation
·
2
Mdb-68. Discovering Drug Sensitivities in Medulloblastoma Using Patient- and Pdx-derived Tumoroids
2024
·
Chris Meulenbroeks
, Phylicia Stathi
, et al.
·
Neuro-Oncology
·
2
PDF
INSP-15. ITCC-P4: A sustainable platform of molecularly well-characterized PDX models of pediatric cancers for high throughputin vivo testing
2022
·
Marcel Kool
, Aniello Federico
, et al.
·
Neuro-Oncology
·
2
Etmr-03. the Role of Foxr2 in Pediatric Brain Cancer
2020
·
Felix Schmitt-Hoffner
, Sjoerd van Rijn
, et al.
·
Neuro-Oncology
·
2
PDF
Abstract 234: ITCC-P4: Genomic profiling and analyses of pediatric patient tumor and patient-derived xenograft (PDX) models for high throughput in vivo testing
2023
·
Apurva Gopisetty
, Aniello Federico
, et al.
·
Cancer Research
·
1
Data from The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers
2026
·
Aniello Federico
, Apurva Gopisetty
, et al.
Supplementary Table 1 from The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers
2026
·
Aniello Federico
, Apurva Gopisetty
, et al.
Supplementary Figure S3 from The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers
2026
·
Aniello Federico
, Apurva Gopisetty
, et al.
Supplementary Figure 1 from The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers
2026
·
Aniello Federico
, Apurva Gopisetty
, et al.
Supplementary Table 5 from The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers
2026
·
Aniello Federico
, Apurva Gopisetty
, et al.
Supplementary Methods from The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers
2026
·
Aniello Federico
, Apurva Gopisetty
, et al.
Supplementary Figure S2 from The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers
2026
·
Aniello Federico
, Apurva Gopisetty
, et al.
Supplementary Table 4 from The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers
2026
·
Aniello Federico
, Apurva Gopisetty
, et al.
Supplementary Figure S6 from The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers
2026
·
Aniello Federico
, Apurva Gopisetty
, et al.
Supplementary Figure S7 from The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers
2026
·
Aniello Federico
, Apurva Gopisetty
, et al.
Show more works
View as search
Works count:
45
Citation count:
609
H-index:
7
I10-index:
5
Year
Topic
Type